Explorer les evidences

14 %In sub-Saharan Africa, only 14% of women aged 30 to 49 years have been screened for cervical cancer.

Kenyacancer du col de l'utéruspublié 2026BMC cancerPubMeddocument de 12 observations

3 per_317Among 317 women, invasive cervical cancer cases included HPV81 in 3/317 (0.9%).

Kenyacancer du col de l'utéruspublié 2021BioMed research internationalPubMeddocument de 9 observations

21,1 monthsThe median overall survival was 21.1 months among HIV-negative patients.

Kenyacancer du col de l'utérusobservé 2014–2023publié 2026BMC cancerPubMeddocument de 16 observations

1 000 USDThe average lifetime cost per cervical cancer case is $1,000–$3,000.

Kenyacancer du col de l'utéruspublié 2025PloS onePubMeddocument de 3 observations

14 daysThe histopathology laboratory at Moi Teaching and Referral Hospital maintained an average 14-day turnaround time for cervical cancer pathology reports between 2018 and 2022.

Kenyacancer du col de l'utérusobservé 2018–2022publié 2025BMC cancerPubMeddocument de 4 observations

43 %From 1st July 2022 to 30th June 2023, the number of facilities offering cervical cancer screening services increased from 23% to 43% of Fahari ya Jamii project-supported HIV clinics in Nairobi and Kajiado Counties.

Kenyacancer du col de l'utérusobservé 1st July 2022 to 30th June 2023publié 2025BMC women's healthPubMeddocument de 8 observations

Cervical cancer remains a common and deadly cancer in areas without screening programs.

Kenyacancer du col de l'utéruspublié 2021JAMA network openPubMeddocument de 11 observations

38,7 %38.7% of women previously screened for cervical cancer underwent screening within the previous year.

Kenyacancer du col de l'utéruspublié 2025BMC women's healthPubMeddocument de 8 observations

3,8 %The overall cervical cancer screening positivity was 3.8% across the 19 facilities in Siaya and Busia counties of Kenya from September 2021 to September 2022.

Kenyacancer du col de l'utérusobservé September 2021 to September 2022publié 2025JCO global oncologyPubMeddocument de 3 observations

184 000 casesAccelerated scale-up of 1-dose bivalent vaccine (2vHPV) would avert 184,000 cervical cancer cases compared with no vaccination.

Kenyacancer du col de l'utérusPubMeddocument de 6 observations

32,3 %Cervical cancer screening was reported in 32.3% of women living with HIV attending infant immunization clinics in Kenya.

Kenyacancer du col de l'utérusobservé 2018 and 2019publié 2025BMC women's healthPubMeddocument de 8 observations

25 %Sub-Saharan Africa accounts for a quarter of global cervical cancer deaths.

Kenyacancer du col de l'utéruspublié 2026BMC cancerPubMeddocument de 12 observations

4 %4% of women previously screened for cervical cancer reported an abnormal screening result.

Kenyacancer du col de l'utéruspublié 2025BMC women's healthPubMeddocument de 8 observations

53,8 %Positive lymph nodes were the most common high-risk feature, occurring in 53.8% of people living with HIV and 40.0% of HIV-negative patients.

Kenyacancer du col de l'utérusobservé 2014–2023publié 2026BMC cancerPubMeddocument de 16 observations

90 %Over 90% of cervical cancer-related deaths occur in low income countries.

Kenyacancer du col de l'utéruspublié 2022Frontiers in public healthPubMeddocument de 4 observations

0,16 hazard_ratioThose who underwent surgical management had 84% reduced hazard of mortality compared to those who were referred for other modes of care: HR: 0.16.

Kenyacancer du col de l'utéruspublié 2023BMC cancerPubMeddocument de 12 observations

6 timesWomen living with HIV are six times more likely to develop cervical cancer as compared to HIV-uninfected women in sub-Saharan Africa.

Kenyacancer du col de l'utéruspublié 2026BMC cancerPubMeddocument de 12 observations

42 %HPV vaccination could reduce the cervical cancer burden by 42–60 %.

Kenyacancer du col de l'utérus · infection à HPVpublié 2023VaccinePubMeddocument de 6 observations

5,2 %Of 632 patients, 5.2% received guideline-adherent cancer-directed therapy.

Kenyacancer du col de l'utéruspublié 2021The oncologisteurope_pmcdocument de 14 observationsDOI 10.1002/onco.13718

33,1 %The average relative survival from cervical cancer in the 11 countries was 33.1% at 5 years.

Kenyacancer du col de l'utérusobservé 2005 to 2015publié 2020International journal of cancereurope_pmcdocument de 6 observations

Screening uptake improved in the intervention arm while declined in the control arm.

Kenyacancer du col de l'utéruspublié 2022Journal of cancer education : the official journal of the American Association for Cancer PubMeddocument de 3 observations

44 %Breast and cervical cancers accounted for 44% of all cancers in women in Nairobi during 2004–2008.

Kenyacancer du col de l'utérus · cancer du seinobservé 2004-2008publié 2015International journal of cancereurope_pmcdocument de 9 observations

56 %Among women attending large HIV care and treatment programs across Kenya between June and September 2016, 1671 of 3007 (56%) reported ever being screened for cervical cancer.

Kenyacancer du col de l'utérusobservé June and September 2016publié 2022International journal of gynaecology and obstetrics: the official organ of the InternationPubMeddocument de 3 observations

275 000 deaths_per_yearCervical cancer claims the lives of 275,000 women each year.

Kenyacancer du col de l'utéruspublié 2014BMC public healtheurope_pmcdocument de 2 observations

85 %Approximately eighty five percent (211/247) of the study respondents were aware of cervical cancer.

Kenyacancer du col de l'utéruspublié 2016Journals & Books Hosting (International Knowledge Sharing Platform)OpenAlexdocument de 18 observations